BIOMARIN PHARMACEUTICAL INC Comprehensive Income
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Comprehensive Income of $40.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $40.22M, a 77.26% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $114.76M, a 19.85% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$26.11M, a 114.35% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$20.12M, a 123.97% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $273.77M, a 47.08% decline from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $517.30M, a 262.45% increase from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $142.72M, a 15.79% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $123.26M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $40.22M 10-Q · filed 2026-08-06 | $154.98M 10-Q · filed 2026-08-06 | $128.87M derived: sum of 3 quarters · filed 2026-08-06 | $108.75M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $114.76M 10-Q · filed 2026-05-05 | $88.65M derived: sum of 2 quarters · filed 2026-05-05 | $68.54M derived: sum of 3 quarters · filed 2026-05-05 | $245.35M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$26.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$46.23M derived: sum of 2 quarters · filed 2026-02-26 | $130.59M derived: sum of 3 quarters · filed 2026-08-06 | $273.77M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$20.12M 10-Q · filed 2025-10-28 | $156.70M derived: sum of 2 quarters · filed 2026-08-06 | $299.88M 10-Q · filed 2025-10-28 | $481.83M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $176.82M 10-Q · filed 2026-08-06 | $320.00M 10-Q · filed 2026-08-06 | $501.95M derived: sum of 3 quarters · filed 2026-08-06 | $585.88M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $143.18M 10-Q · filed 2026-05-05 | $325.13M derived: sum of 2 quarters · filed 2026-05-05 | $409.06M derived: sum of 3 quarters · filed 2026-05-05 | $544.08M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $181.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $265.88M derived: sum of 2 quarters · filed 2026-02-26 | $400.90M derived: sum of 3 quarters · filed 2026-02-26 | $517.30M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $83.93M 10-Q · filed 2025-10-28 | $218.95M derived: sum of 2 quarters · filed 2025-10-28 | $335.35M 10-Q · filed 2025-10-28 | $320.68M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $135.02M 10-Q · filed 2025-08-05 | $251.42M 10-Q · filed 2025-08-05 | $236.75M derived: sum of 3 quarters · filed 2026-02-26 | $302.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $116.40M 10-Q · filed 2025-05-02 | $101.73M derived: sum of 2 quarters · filed 2026-02-26 | $166.99M derived: sum of 3 quarters · filed 2026-02-26 | $215.13M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$14.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $50.58M derived: sum of 2 quarters · filed 2026-02-26 | $98.73M derived: sum of 3 quarters · filed 2026-02-26 | $142.72M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $65.25M 10-Q · filed 2024-10-31 | $113.40M derived: sum of 2 quarters · filed 2024-10-31 | $157.39M 10-Q · filed 2024-10-31 | $122.53M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2023-06-30 | $48.15M 10-Q · filed 2024-08-05 | $92.14M 10-Q · filed 2024-08-05 | $57.28M derived: sum of 3 quarters · filed 2025-02-24 | $62.90M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2023-03-31 | $44.00M 10-Q · filed 2024-04-26 | $9.13M derived: sum of 2 quarters · filed 2025-02-24 | $14.76M derived: sum of 3 quarters · filed 2025-02-24 | $61.77M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2022-12-31 | -$34.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | -$29.24M derived: sum of 2 quarters · filed 2025-02-24 | $17.77M derived: sum of 3 quarters · filed 2025-02-24 | $123.26M 10-K · filed 2025-02-24 | ||||
| 2022-09-30 | $5.63M 10-Q · filed 2023-11-02 | $52.64M derived: sum of 2 quarters · filed 2023-11-02 | $158.13M 10-Q · filed 2023-11-02 | $104.42M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $47.01M 10-Q · filed 2023-08-02 | $152.50M 10-Q · filed 2023-08-02 | $98.80M derived: sum of 3 quarters · filed 2024-02-26 | $73.48M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | $105.49M 10-Q · filed 2023-04-28 | $51.78M derived: sum of 2 quarters · filed 2024-02-26 | $26.47M derived: sum of 3 quarters · filed 2024-02-26 | $33.47M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | -$53.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$79.02M derived: sum of 2 quarters · filed 2024-02-26 | -$72.02M derived: sum of 3 quarters · filed 2024-02-26 | -$33.51M 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | -$25.32M 10-Q · filed 2022-10-28 | -$18.32M derived: sum of 2 quarters · filed 2022-10-28 | $20.20M 10-Q · filed 2022-10-28 | $10.70M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $7.00M 10-Q · filed 2022-08-04 | $45.51M 10-Q · filed 2022-08-04 | $36.02M derived: sum of 3 quarters · filed 2023-02-27 | $801.15M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $38.51M 10-Q · filed 2022-04-29 | $29.02M derived: sum of 2 quarters · filed 2023-02-27 | $794.16M derived: sum of 3 quarters · filed 2023-02-27 | $760.90M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | -$9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $755.64M derived: sum of 2 quarters · filed 2023-02-27 | $722.38M derived: sum of 3 quarters · filed 2023-02-27 | $817.73M 10-K · filed 2023-02-27 | $822.80M 10-K · filed 2021-02-26 | |||
| 2020-09-30 | $765.14M 10-Q · filed 2021-10-29 | $731.88M derived: sum of 2 quarters · filed 2021-10-29 | $827.22M 10-Q · filed 2021-10-29 | $825.41M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | -$33.26M 10-Q · filed 2021-07-30 | $62.08M 10-Q · filed 2021-07-30 | $60.27M derived: sum of 3 quarters · filed 2022-02-25 | $134.87M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $95.34M 10-Q · filed 2021-04-30 | $93.53M derived: sum of 2 quarters · filed 2022-02-25 | $168.13M derived: sum of 3 quarters · filed 2022-02-25 | $128.34M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | -$1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $72.78M derived: sum of 2 quarters · filed 2022-02-25 | $32.99M derived: sum of 3 quarters · filed 2022-02-25 | -$8.96M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $74.60M 10-Q · filed 2020-11-06 | $34.81M derived: sum of 2 quarters · filed 2020-11-06 | -$7.14M 10-Q · filed 2020-11-06 | -$3.36M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | -$39.79M 10-Q · filed 2020-08-05 | -$81.74M 10-Q · filed 2020-08-05 | -$77.96M derived: sum of 3 quarters · filed 2021-02-26 | -$91.61M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | -$41.95M 10-Q · filed 2020-05-01 | -$38.17M derived: sum of 2 quarters · filed 2021-02-26 | -$51.82M derived: sum of 3 quarters · filed 2021-02-26 | -$41.20M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $3.78M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | -$9.87M derived: sum of 2 quarters · filed 2021-02-26 | $754.00K derived: sum of 3 quarters · filed 2021-02-26 | -$48.39M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | -$13.65M 10-Q/A · filed 2019-11-04 | -$3.03M derived: sum of 2 quarters · filed 2019-11-04 | -$52.17M 10-Q/A · filed 2019-11-04 | -$105.09M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $10.62M 10-Q · filed 2019-08-02 | -$38.52M 10-Q · filed 2019-08-02 | -$91.44M derived: sum of 3 quarters · filed 2020-02-27 | -$110.75M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$49.15M 10-Q · filed 2019-04-29 | -$102.07M derived: sum of 2 quarters · filed 2020-02-27 | -$121.37M derived: sum of 3 quarters · filed 2020-02-27 | -$177.88M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | -$52.92M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$72.22M derived: sum of 2 quarters · filed 2020-02-27 | -$128.73M derived: sum of 3 quarters · filed 2020-02-27 | -$152.82M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | -$19.30M 10-Q · filed 2018-10-26 | -$75.81M derived: sum of 2 quarters · filed 2018-10-26 | -$99.90M 10-Q · filed 2018-10-26 | -$179.96M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | -$56.51M 10-Q · filed 2018-08-03 | -$80.60M 10-Q · filed 2018-08-03 | -$160.66M derived: sum of 3 quarters · filed 2019-02-28 | -$200.45M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | -$24.09M 10-Q · filed 2018-04-27 | -$104.15M derived: sum of 2 quarters · filed 2019-02-28 | -$143.94M derived: sum of 3 quarters · filed 2019-02-28 | -$558.48M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | -$80.06M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$119.86M derived: sum of 2 quarters · filed 2019-02-28 | -$534.39M derived: sum of 3 quarters · filed 2019-02-28 | -$638.43M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | -$39.80M 10-Q · filed 2017-10-31 | -$45.17M 10-Q · filed 2016-11-03 | -$454.33M derived: sum of 2 quarters · filed 2017-10-31 | -$558.37M 10-Q · filed 2017-10-31 | -$570.37M 10-Q · filed 2016-11-03 | -$493.90M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-06-30 | -$414.53M 10-Q · filed 2017-08-02 | -$419.08M 10-Q · filed 2016-08-08 | -$518.57M 10-Q · filed 2017-08-02 | -$525.21M 10-Q · filed 2016-08-08 | -$454.10M derived: sum of 3 quarters · filed 2018-02-26 | -$552.31M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-03-31 | -$104.04M 10-Q · filed 2017-05-04 | -$106.13M 10-Q · filed 2016-05-02 | -$39.57M derived: sum of 2 quarters · filed 2018-02-26 | -$137.77M derived: sum of 3 quarters · filed 2018-02-26 | -$231.12M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2015-12-31 | $64.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$33.74M derived: sum of 2 quarters · filed 2018-02-26 | -$127.08M derived: sum of 3 quarters · filed 2018-02-26 | -$178.23M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | -$98.20M 10-Q · filed 2016-11-03 | -$191.55M derived: sum of 2 quarters · filed 2016-11-03 | -$242.70M 10-Q · filed 2016-11-03 | -$304.22M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | -$93.35M 10-Q · filed 2016-08-08 | -$144.50M 10-Q · filed 2016-08-08 | -$206.01M derived: sum of 3 quarters · filed 2017-02-27 | -$189.32M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | -$51.15M 10-Q · filed 2016-05-02 | -$112.67M derived: sum of 2 quarters · filed 2017-02-27 | -$95.97M derived: sum of 3 quarters · filed 2017-02-27 | -$126.81M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | -$61.52M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$44.83M derived: sum of 2 quarters · filed 2017-02-27 | -$75.66M derived: sum of 3 quarters · filed 2017-02-27 | -$111.52M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $16.69M 10-Q · filed 2015-11-02 | -$14.14M derived: sum of 2 quarters · filed 2015-11-02 | -$50.00M 10-Q · filed 2015-11-02 | -$118.45M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | -$30.84M 10-Q · filed 2015-08-05 | -$66.69M 10-Q · filed 2015-08-05 | -$135.14M derived: sum of 3 quarters · filed 2016-02-29 | -$179.13M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$35.86M 10-Q · filed 2015-05-05 | -$104.30M derived: sum of 2 quarters · filed 2016-02-29 | -$148.29M derived: sum of 3 quarters · filed 2016-02-29 | -$168.54M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | -$68.44M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$112.43M derived: sum of 2 quarters · filed 2016-02-29 | -$132.68M derived: sum of 3 quarters · filed 2016-02-29 | -$171.13M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | -$43.99M 10-Q · filed 2014-10-28 | -$64.23M derived: sum of 2 quarters · filed 2014-10-28 | -$102.69M 10-Q · filed 2014-10-28 | -$158.24M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | -$20.25M 10-Q · filed 2014-07-31 | -$58.70M 10-Q · filed 2014-07-31 | -$114.25M derived: sum of 3 quarters · filed 2015-03-02 | -$121.92M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | -$38.45M 10-Q · filed 2014-05-02 | -$94.00M derived: sum of 2 quarters · filed 2015-03-02 | -$101.67M derived: sum of 3 quarters · filed 2015-03-02 | -$131.54M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | -$55.55M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$63.22M derived: sum of 2 quarters · filed 2015-03-02 | -$93.09M derived: sum of 3 quarters · filed 2015-03-02 | -$119.44M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | -$7.67M 10-Q · filed 2013-10-28 | -$37.54M derived: sum of 2 quarters · filed 2013-10-28 | -$63.89M 10-Q · filed 2013-10-28 | -$87.04M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-06-30 | -$29.87M 10-Q · filed 2013-07-29 | -$56.22M 10-Q · filed 2013-07-29 | -$79.37M derived: sum of 3 quarters · filed 2014-02-26 | -$89.79M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-03-31 | -$26.35M 10-Q · filed 2013-04-29 | -$49.50M derived: sum of 2 quarters · filed 2014-02-26 | -$59.92M derived: sum of 3 quarters · filed 2014-02-26 | -$65.14M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2011-12-31 | -$23.15M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | -$33.58M derived: sum of 2 quarters · filed 2014-02-26 | -$38.79M derived: sum of 3 quarters · filed 2014-02-26 | -$49.14M 10-K · filed 2014-02-26 | ||||
| 2011-09-30 | -$10.43M 10-Q · filed 2012-10-29 | -$10.40M 10-Q · filed 2011-10-31 | -$15.64M derived: sum of 2 quarters · filed 2012-10-29 | -$25.98M 10-Q · filed 2012-10-29 | -$26.00M 10-Q · filed 2011-10-31 | -$36.41M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-06-30 | -$5.21M 10-Q · filed 2012-08-02 | $5.20M 10-Q · filed 2011-08-01 | -$15.56M 10-Q · filed 2012-08-02 | $15.60M 10-Q · filed 2011-08-01 | -$25.98M derived: sum of 3 quarters · filed 2013-02-26 | $179.51M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-03-31 | -$10.35M 10-Q · filed 2012-04-30 | -$20.77M derived: sum of 2 quarters · filed 2013-02-26 | $184.73M derived: sum of 3 quarters · filed 2013-02-26 | $190.03M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | -$10.43M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $195.07M derived: sum of 2 quarters · filed 2013-02-26 | $200.37M derived: sum of 3 quarters · filed 2013-02-26 | $205.07M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $205.50M 10-Q · filed 2011-10-31 | $210.80M derived: sum of 2 quarters · filed 2011-10-31 | $215.50M 10-Q · filed 2011-10-31 | |||||
| 2010-06-30 | $5.30M 10-Q · filed 2011-08-01 | $10.00M 10-Q · filed 2011-08-01 | ||||||
| 2009-12-31 | -$661.00K 10-K · filed 2012-02-22 | |||||||
| 2008-12-31 | $31.80M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |